Smoking Human Lung Small Airway on a Chip

TL;DR

Organs-on-chips technology shows promise in providing a more clinically relevant model for studying COPD and other smoking-related diseases.

Transcript

chronic obstructive pulmonary disease commonly known as COPD is currently the third leading cause of death in humans around the world and the major risk factor is cigarette smoke exposure COPD is one of the major health problems today and there very few drugs that we can offer right now I think it's very hard to get insight into the mechanism of th... Read More

Key Insights

• 🧑‍⚕️ COPD is a significant global health problem, and current treatment options are limited.
• 🫁 Studying cells in isolation or using animal models has limitations in mimicking human lung physiology and predicting clinical outcomes.
• 🐿️ Organs-on-chips technology offers a more accurate and controlled model for studying smoking-related diseases like COPD.
• 👻 This technology eliminates inter-individual variability and allows for comparative studies.
• 🐿️ Organs-on-chips technology provides a platform for advancing drug development and studying toxicity of smoking-related products.
• 👻 The ability to recreate the same individual's lung airway allows for accurate before-and-after environmental perturbation studies.
• 😒 The use of organs-on-chips technology may lead to advancements in understanding and treating COPD.

Questions & Answers

Q: What is COPD, and what is its major risk factor?

COPD is a chronic disease causing lung inflammation and reduced airflow, primarily caused by cigarette smoke exposure.

Q: What are the limitations of studying cells in isolation or animal models?

Cells function differently when they are in the context of their tissue or organ, making it challenging to understand disease mechanisms. Animal studies have ethical, cost, and time issues, and results often do not translate to humans.

Q: How does organs-on-chips technology address the limitations?

Organs-on-chips technology recreates miniature organs with living cells, mimicking the normal physiology of human organs. It allows for the study of complex functions, including inflammation and infection, and provides a more clinically relevant model for disease research.

Q: What are the components of the developed platform for studying smoking effects?

The platform includes a smoking lung apparatus, a ribcage and diaphragm mimicking device, a small airway chip, and a smoke machine. The software controls the breathing and smoking behavior parameters.

Summary & Key Takeaways

• COPD is a major health problem globally, with few effective drugs available.

• Animal models and cell cultures have limitations in mimicking human lung physiology and predicting clinical trial outcomes.

• Organs-on-chips technology offers a more accurate and controllable way to study smoking effects on human lungs.

• This technology eliminates inter-individual variability, allowing for more accurate comparative studies.